Sector: Industrials | Industry: Industrial Machinery & Equipment |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 28601 Clemens Rd WESTLAKE OH 44145 |
Tel: | N/A |
Website: | https://www.nordson.com |
IR: | See website |
Key People | ||
Sundaram Nagarajan President, Chief Executive Officer, Director | Stephen Shamrock Interim Chief Financial Officer, Vice President, Corporate Controller | Sarah Siddiqui Chief Human Resource Officer, Executive Vice President |
Jennifer L. Mcdonough Executive Vice President, General Counsel, Secretary | James E. DeVries Executive Vice President - Continuous Improvement | Joseph P. Kelley Executive Vice President and Industrial Precision Solutions Segment Leader |
Stephen P. Lovass Executive Vice President - Medical and Fluid Solutions | Srinivas Subramanian Executive Vice President - Advanced Technology Solutions |
Business Overview |
Nordson Corporation is a precision technology company. It engineers, manufactures and market differentiated products and systems used for precision dispensing, applying and controlling adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treat and cure surfaces and various medical products. Its segments include Industrial Precision Solutions, Medical and Fluid Solutions and Advanced Technology Solutions. The Industrial Precision Solutions segment delivers dispensing and material processing technology to diverse end markets. This segment serves the consumer durables, non-durables, agriculture and industrial markets. The Medical and Fluid Solutions segment includes fluid management solutions for medical, high-tech industrial and other diverse end markets. The Advanced Technology Solutions segment integrates its product technologies into the progressive stages of a customer's production processes. |
Financial Overview |
For the three months ended 31 January 2024, Nordson Corp revenues increased 4% to $633.2M. Net income increased 5% to $109.6M. Revenues reflect Industrial Precisions solutions segment increase of 14% to $354.5M, Medical and Fluid Solutions segment increase of 3% to $159.5M, Europe segment increase of 10% to $179.3M, Americas segment increase of 3% to $274M. |
Employees: | 7,900 as of Jan 31, 2024 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $16,411M as of Jan 31, 2024 |
Annual revenue (TTM): | $2,651M as of Jan 31, 2024 |
EBITDA (TTM): | $806.99M as of Jan 31, 2024 |
Net annual income (TTM): | $492.80M as of Jan 31, 2024 |
Free cash flow (TTM): | $505.48M as of Jan 31, 2024 |
Net Debt Last Fiscal Year: | $1,511M as of Jan 31, 2024 |
Shares outstanding: | 57,192,245 as of Jan 31, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |